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1. Introduction 
By combined use of new derivatives it has been 
possible to sequenate rather larger lipid-linked oligo- 
saccharides by mass spectrometry [ 1,2] . LiAlH4 
reduction of amide groups in permethylated deriva- 
tives [ 1 ] affords stabilization of high molecular 
weight fragments, thus far allowing a conclusive com- 
position and sequence analysis of as large a molecule 
as a nonaglycosylceramide [2%4]. We therefore 
judged it of interest to test if the same procedure was 
successful on glycopeptides of the type liberated 
from glycoproteins by extensive proteolytic digestion 
(see [5]). In this paper the sialoglycopeptide and the 
asialoglycopeptide of human transferrin will be briefly 
discussed. 
2. Materials and methods 
The glycopeptides were prepared from commercial 
transferrin (grade II, Sigma). The denatured glyco- 
protein was extensively digested with pronase [6]. The 
glycopeptides obtained were purified by gel filtration 
on Sephadex G-25 and fractionated on a concanavalin 
A-Sepharose column asin [7]. Part of the pure glyco- 
peptide was treated with neuraminidase [S] . Salts 
and enzyme were removed on a Sephadex G-50 
column. The two glycopeptide fractions were 
N-acetylated [8] and methylated [9,10]. The reduc- 
tion with LiAlH4 and silylation were done as in [ 111. 
The mass spectrometer used was MS 902 (AEI Ltd.) 
and the direct inlet system was equipped with a 
ElsevierlNorth-Holland Biomedical Press 
separate probe heater. The conditions of analysis are 
given in the figure legends. 
3. Results 
As is usually the case for sialic acidcontaining 
glycolipids [2] three derivatives were analysed: 
methylated, methylated-reduced, and methylated- 
reducedsilylated compounds. The reduction converts 
amide to amine (loss of 14 mass units), and methyl 
ester (of sialic acid and amino acid) to alcohol (loss of 
29 mass units). By silylation 72 mass units are added 
to each alcohol group produced. Only spectra of two 
types of derivatives are reproduced (fig.1 -4). Although 
the amino acid composition was not confirmed, the 
formulae at the spectra are shown with Ser-Asn. The 
sugar part is drawn simplified from the structure 
recently confirmed by NMR spectroscopy [ 121. 
Spectra and formulae of methylated and 
methylated-reduced erivatives of the sialic acid-con- 
taining glycopeptide are shown in fig.1 and 2, respec- 
tively . 
The presence of a terminal sialic acid is shown by 
m/e 376 and 344 (loss of methanol), see fig.1, and 
318 and 302 (fig.2). The ions at m/e 142 (fig.1) and 
128,232 and 248 (fig.2) are also derived from sialic 
acid [2,11,13]. The peak at m/e 128 (fig.2) is specific 
for N-acetylneuraminic acid. In case of N-glycoloyl- 
neuraminic acid m/e 158 was found as the base 
peak [14]. 
The terminal disaccharide is indicated by frag- 
ments at m/e 580 and 536 (fig.l), and the trisaccharide 
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at 825,793 and 765 [ll], see fig.1, and at 785,769 
and also at 452 and 435 (452-16-l), see fig.2. The 
sequence of the complete branch (tetrasaccharide) is 
finally established by the ions at m/e 1029 and 969 
(fig.1) and possibly 1001 (cf. analogous fragment of 
fig.3), see fig.2. 
The base peak at m/e 182 (fig.l,3) is diagnostic 
for a monosubstituted glucosamine with a 14 linkage 
[3]. Although there are still some peaks not yet iden- 
tified we have so far found no fragments of value for 
establishing the kind of amino acids present. Some 
peaks which are common to fig.l,3, and fig.2,4, 
respectively, are sugar peaks and due to admixture of 
the two compounds to each other (e.g., m/e 825, 
793,765,464 and 432 of fig.l,3, and 466 of fig.2,4). 
Upon silylation (spectrum not reproduced) there 
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Fig.3. Mass spectrum of N-acetylated and permethylated asialoglycopeptide obtained from human transferrin. The conditions of 
analysis were: electron energy 70 eV; trap current 500 PA; acceleration voltage 6 kV; ion source temp. 255°C; probe temp. 230°C. 
Fig.1. Mass spectrum of N-acetylated and permethylated glycopeptide obtained from human transferrin. NANA means N-acetyl- 
neuraminic acid. The conditions of analysis were: electron energy 70 eV; trap current 500 @A; acceleration voltage 6 kV; ion 
source temp. 255°C; probe temp. 250°C. 
Fig.2. Mass spectrum of N-acetylated, permethylated and reduced glycopeptide obtained from human transferrin. NANA means 
N-acetylneuraminic acid. The conditions of analysis were: electron energy 60 eV; trap current 500 PA; acceleration voltage 6 kV; 
ion source temp. 26O’C; probe temp. 280°C. 
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Fig.4. Mass spectrum of N-acetylated, permethylated and reduced asialoglycopeptide obtained from human transferrin. The con- 
ditions of analysis were: electron energy 60 eV; trap current 500 PA; acceleration voltage 6 kV; ion source temp. 260°C; probe 
temp. 270°C. 
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are some significant changes for sugar peaks but again 
no information concerning amino acids. Strong ions 
diagnostic for the trisaccharide were found at m/e 524 
(857-406+73) and 507 (524-16-l), compare 
[ 11,131, and for the tetrasaccharide at 728 (106 l- 
406+73) and 7 12 (728-16). In addition there was 
an even distribution of low-intensity peaks up to 
about m/e 2 100, but these were not easily inter- 
pretable. 
For the asialoglycopeptide (fig.3,4) sequence ions 
for the trisaccharide branch are found at m/e 187, 
219,432,464,636,668 and 696 for the methylated 
derivative (tig.3), and at m/e 449 (450-l) 466,654 
and 670 for the methylated-reduced erivative (fig.4). 
Of special interest is the spectrum of fig.4, which 
gives information for the complete nonasaccharide. 
The practical absence of distinct peaks between m/e 
670 and 1497 is an indication of the branched struc- 
ture. Then following is a series of peaks including the 
remaining trisaccharide linked to the peptide, namely 
m/e 1513,1728,1744 and 1959. Some rather abun- 
dant additional ions have not yet been identified 
(m/e332,519,533,1671 and 1872).It may be noted 
that the mass difference of 533 and 332 is the same 
as of 1872 and 1671, namely 201. The difference of 
1872 and 533 is about the mass of the two branches, 
indicating that this series may come from secondary 
fragmentations from the peptide end. 
After silylation there is practically no change of the 
mass spectrum (not reproduced). This is expected if 
the peptide part, where a trimethylsilyl group is 
added (cf. formula of fig.4) does not show up with 
primary ions in the spectrum (cf. data from the 
sialoderivative). 
4. Discussion 
The results show that this mass spectrometric 
technique is as well applicable on glycopeptides as on 
glycolipids [l-3]. Although there is no specific infor- 
mation from the peptide part, in contrast to the case 
for the lipophilic part of glycolipids, the presence of 
the peptide may nevertheless be of importance for 
directing a primary fragmentation from the terminal 
sugar end. The method should be useful for a micro- 
scale fingerprinting of mixtures of glycopeptides 
released from glycoproteins by proteolytic digestion 
[5]. By a programmed temperaturedependent evapo- 
ration in the ion source one may obtain a separation 
according to the number of sugars. We have recently 
developed a computer-based technique of this kind for 
glycolipids [ 151. 
Of relevance now is a detailed study of glyco- 
peptides ofless complexity and with varying structure, 
to learn if the specificity and unambiguity of the 
mass spectrometric information is as great as for 
glycolipids. 
The present result is also a confirmation with an 
independent method of the oligosaccharide structure 
of human transferrin (discussed in [ 121). 
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